HF
ALXN

HRT Financial’s Alexion Pharmaceuticals ALXN Stock Holding History

HRT Financial’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8,478
Closed -$761K – 1837
2020
Q1 		$761K Buy
+8,478
New +$832K 0.05% 308
2019
Q4 		– Sell
-2,578
Closed -$252K – 1842
2019
Q3 		$252K Buy
+2,578
New +$291K 0.01% 1033
2015
Q4 		– Sell
-1,300
Closed -$203K – 128
2015
Q3 		$203K Buy
+1,300
New +$237K 0.17% 76

Other funds holding ALXN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HRT Financial's ALXN Position: Q2 2020 in Review

HRT Financial sold out of Alexion Pharmaceuticals (ALXN) in Q2 2020, closing a stake of 8,478 shares — an estimated $761K sold.

HRT Financial first reported a position in ALXN in Q3 2015 and held it in 3 quarters. The position peaked at $761K in Q1 2020. 705 funds tracked by Wall St. Rank hold ALXN as of Q2 2020.

  • HRT Financial reported no remaining Alexion Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • HRT Financial sold 8,478 Alexion Pharmaceuticals shares in Q2 2020, an estimated $761K.
  • HRT Financial first reported a position in Alexion Pharmaceuticals in Q3 2015 and held it in 3 quarters.
  • HRT Financial's Alexion Pharmaceuticals position peaked at $761K in Q1 2020.
  • 705 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2020.

Based on HRT Financial's 13F filing for Q2 2020, filed 14 Aug 2020.